Corteva defends separation amid PFAS claims
Compartilhar
Corteva (NYSE:CTVA) rejected efforts by several State Attorneys General to stop its planned separation, stating that the legal challenge is based on speculative PFAS liability claims.
Corteva (NYSE:CTVA) rejected efforts by several State Attorneys General to stop its planned separation, stating that the legal challenge is based on speculative PFAS liability claims.
Corteva (NYSE:CTVA) and bp (NYSE:BP) announced on Wednesday, January 7, 2026, the formation of Etlas, a 50:50 joint venture aimed at scaling the production of crop-based oil feedstocks.
Corteva (NYSE:CTVA), the agricultural technology giant, and Hexagon Bio, a biotechnology company focused on nature-derived therapeutics, announced a multi-million-dollar joint venture aimed at accelerating the discovery of new crop protection solutions.
Corteva (NYSE:CTVA) and Globachem agreed to establish a 50/50 joint venture focused on developing new crop protection products for farmers in Europe and the Americas.
